DAE HWA Pharmaceutical Co. Ltd (067080) — Cash Flow Quality Index
DAE HWA Pharmaceutical Co. Ltd (067080) has a Cash Flow Quality Index of 0.65x as of December 2025. Operating cash flow of ₩2.06 Billion is below net income of ₩3.18 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore DAE HWA Pharmaceutical Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DAE HWA Pharmaceutical Co. Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for DAE HWA Pharmaceutical Co. Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 067080 cash flow conversion.
Annual Cash Flow Quality Index for DAE HWA Pharmaceutical Co. Ltd (2011–2025)
Year-by-year earnings quality comparison for DAE HWA Pharmaceutical Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.28x | ₩5.43 Billion | ₩1.65 Billion | ▼ -55.5% |
| 2024 | 7.38x | ₩6.13 Billion | ₩829.83 Million | ▲ +12.0% |
| 2022 | 6.59x | ₩8.05 Billion | ₩1.22 Billion | ▲ +23.8% |
| 2021 | 5.32x | ₩10.45 Billion | ₩1.96 Billion | ▲ +136721.3% |
| 2019 | 0.00x | ₩-41.07 Million | ₩10.54 Billion | ▼ -100.2% |
| 2018 | 1.58x | ₩10.49 Billion | ₩6.65 Billion | ▲ +82.4% |
| 2017 | 0.86x | ₩10.94 Billion | ₩12.65 Billion | ▼ -63.3% |
| 2016 | 2.36x | ₩8.79 Billion | ₩3.73 Billion | ▲ +298.6% |
| 2015 | 0.59x | ₩2.43 Billion | ₩4.11 Billion | ▼ -92.7% |
| 2013 | 8.10x | ₩13.57 Billion | ₩1.68 Billion | ▲ +341.9% |
| 2012 | 1.83x | ₩5.77 Billion | ₩3.15 Billion | ▲ +100.9% |
| 2011 | 0.91x | ₩3.43 Billion | ₩3.76 Billion | — |